specialty-pharmaceuticals
(2)
Kyowa Kirin, Inc. - U.S.
A Japanese fermentation lineage became a U.S. rare-disease business by following biology that larger markets often overlook. Now Kyowa Kirin is testing whether patient-scale focus can coexist with manufacturing-scale ambition.
TerSera Therapeutics
TerSera Therapeutics is a privately held biopharmaceutical company based in Deerfield, Illinois, focused on acquiring, developing, and commercializing specialty medicines in oncology, rare disease, and non-opioid pain. Launched in 2016 with backing from private equity firm GTCR, TerSera builds its portfolio through targeted acquisitions of approved and late-stage assets, including ZOLADEX, XERMELO, PRIALT, and VARUBI, with a stated mission of building 'the new cornerstones of care' for patients with limited treatment options.